Stephanie Ragan
Foot & Ankle Surgery · Minneapolis, MNNPI 1114480308
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,987 with a category attached, or 60.4%. Foundation Medical, LLC accounts for 63.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $1,295 and has fallen 84.0% since, to $207 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in MN, where the typical reported total is $2,836.
Across 25 payments — averaging $79.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Medical, LLC$1K
- Reprise Biomedical, Inc.$166
- Stryker$124
- Bone Support Inc.$79
- Next Science LLC$70
- Paragon 28, Inc.$56
- plus $229 from 9 others
What the payments were for
- Food & beverage$78740%
- Education$1,20060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Medical, LLC | 2 | $1,263 |
| Reprise Biomedical, Inc. | 5 | $166 |
| Stryker | 3 | $124 |
| Bone Support Inc. | 1 | $79 |
| Next Science LLC | 2 | $70 |
| Paragon 28, Inc. | 2 | $56 |
| Linvatec Corporation | 1 | $49 |
| Orthofix Medical, Inc. | 2 | $33 |
| Nevro Corp. | 1 | $30 |
| Vertex | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Bioventus LLC | 1 | $23 |
| Curonix LLC | 1 | $17 |
| Medtronic | 1 | $16 |
| Kerecis Limited | 1 | $13 |
How this compares
$1,987 in reported general payments places this provider in the 40th percentile of 102 foot & ankle surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 14 | $2,453 |
| Ketoconazole | 32 | $1,996 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $186 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Minneapolis
- Jessica DownesMinneapolis$8K
- Adam JohnsonMinneapolis$3K
- Nicole BauerlyMinneapolis$2K
- Johannes CoetzeeEdina$4.7M
- Troy BoffeliSaint Paul$1.7M
- Jeffrey SeyboldEdina$270K
- Kyle AbbenSt Louis Park$130K
- Collin MesserlySaint Paul$50K
- Ryan ReinkingDuluth$48K
- Kevin MahoneyMarshall$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.